German Pharma Company Adds Bitcoin to Treasury Reserves
Evertz Pharma GmbH has officially become the first German company to add Bitcoin to its balance sheet.
The Frankfurt-based firm purchased an additional 100 BTC in May 2025, valued at approximately €10 million (~$10.8 million), expanding its group-wide digital asset reserve.
The company began its Bitcoin strategy in 2020 and now reinforces that commitment with this latest acquisition.
Managing Director Dominik Evertz described Bitcoin as a scarce, globally tradable asset that strengthens long-term financial stability.
He said the asset complements the company’s reserves and aligns with its future-focused strategy.
Kosta joined the team in 2021 and quickly established himself with his thirst for knowledge, incredible dedication, and analytical thinking. He not only covers a wide range of current topics, but also writes excellent reviews, PR articles, and educational materials. His articles are also quoted by other news agencies.
